383 related articles for article (PubMed ID: 18640307)
1. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
Veeramachaneni NK; Zoole JB; Decker PA; Putnam JB; Meyers BF;
Ann Thorac Surg; 2008 Aug; 86(2):418-21; discussion 421. PubMed ID: 18640307
[TBL] [Abstract][Full Text] [Related]
2. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.
Rizk N; Venkatraman E; Park B; Flores R; Bains MS; Rusch V;
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1374-81. PubMed ID: 17140960
[TBL] [Abstract][Full Text] [Related]
3. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
Cense HA; van Eijck CH; Tilanus HW
Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
[TBL] [Abstract][Full Text] [Related]
4. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma?
Hu Y; Hu C; Zhang H; Ping Y; Chen LQ
Ann Surg Oncol; 2010 Mar; 17(3):784-90. PubMed ID: 19953333
[TBL] [Abstract][Full Text] [Related]
5. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
[TBL] [Abstract][Full Text] [Related]
6. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction.
Lerut T; Coosemans W; De Leyn P; Deneffe G; Topal B; Van de Ven C; Van Raemdonck D
Hepatogastroenterology; 1999; 46(26):717-25. PubMed ID: 10370600
[TBL] [Abstract][Full Text] [Related]
7. How many lymph nodes are needed for an accurate pN classification in esophageal cancer? Evidence for a new threshold value.
Dutkowski P; Hommel G; Böttger T; Schlick T; Junginger T
Hepatogastroenterology; 2002; 49(43):176-80. PubMed ID: 11941947
[TBL] [Abstract][Full Text] [Related]
8. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
[TBL] [Abstract][Full Text] [Related]
9. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
10. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
11. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes.
Peyre CG; Hagen JA; DeMeester SR; Van Lanschot JJ; Hölscher A; Law S; Ruol A; Ancona E; Griffin SM; Altorki NK; Rice TW; Wong J; Lerut T; DeMeester TR
Ann Surg; 2008 Dec; 248(6):979-85. PubMed ID: 19092342
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
[TBL] [Abstract][Full Text] [Related]
13. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
14. Proposed modification of nodal status in AJCC esophageal cancer staging system.
Hofstetter W; Correa AM; Bekele N; Ajani JA; Phan A; Komaki RR; Liao Z; Maru D; Wu TT; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Walsh GL; Francis A; Blackmon S; Swisher SG
Ann Thorac Surg; 2007 Aug; 84(2):365-73; discussion 374-5. PubMed ID: 17643602
[TBL] [Abstract][Full Text] [Related]
15. Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction.
Mönig SP; Baldus SE; Zirbes TK; Collet PH; Schröder W; Schneider PM; Dienes HP; Hölscher AH
Hepatogastroenterology; 2002; 49(44):419-22. PubMed ID: 11995464
[TBL] [Abstract][Full Text] [Related]
16. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
[TBL] [Abstract][Full Text] [Related]
17. Refining esophageal cancer staging.
Rice TW; Blackstone EH; Rybicki LA; Adelstein DJ; Murthy SC; DeCamp MM; Goldblum JR
J Thorac Cardiovasc Surg; 2003 May; 125(5):1103-13. PubMed ID: 12771884
[TBL] [Abstract][Full Text] [Related]
18. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.
Gockel I; Domeyer M; Sgourakis GG; Schimanski CC; Moehler M; Kirkpatrick CJ; Lang H; Junginger T; Hansen T
J Surg Oncol; 2009 Sep; 100(3):191-8. PubMed ID: 19548259
[TBL] [Abstract][Full Text] [Related]
19. Extent of surgical resection for esophageal and gastroesophageal junction adenocarcinomas.
Vrouenraets BC; van Lanschot JJ
Surg Oncol Clin N Am; 2006 Oct; 15(4):781-91. PubMed ID: 17030273
[TBL] [Abstract][Full Text] [Related]
20. Prognostic variables in thoracic esophageal squamous cell carcinoma.
Lin CS; Chang SC; Wei YH; Chou TY; Wu YC; Lin HC; Wang LS; Hsu WH
Ann Thorac Surg; 2009 Apr; 87(4):1056-65. PubMed ID: 19324127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]